Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David P Carbone

Showing results (161-170 of 283) with videos related to

Pageof 29
Sort By:
Cancer Gene Therapy|December 19, 2002
Recombinant adenoviruses expressing dominant negative insulin-like growth factor-I receptor demonstrate antitumor effects on lung cancerChoon-Taek Lee, Kyung-Ho Park, Yasushi Adachi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 27, 2009
Integration of molecular profiling into the lung cancer clinicWilliam Pao, Mark G Kris, A John Iafrate, et al.
Journal of Gastroenterology|November 11, 2009
Targeting for insulin-like growth factor-I receptor with short hairpin RNA for human digestive/gastrointestinal cancersYu Wang, Yasushi Adachi, Arisa Imsumran, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 14, 2019
Adaptive Resistance to Dual BRAF/MEK Inhibition in BRAF-Driven Tumors through Autocrine FGFR Pathway ActivationVictoria E Wang, Jenny Y Xue, Dennie T Frederick, et al.
JTO Clinical and Research Reports|June 20, 2022
Functional Trajectories and Resilience Among Adults With Advanced Lung CancerCarolyn J Presley, Nicole A Arrato, Peter G Shields, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 2, 2003
A phase I/IIA trial of continuous five-day infusion of squalamine lactate (MSI-1256F) plus carboplatin and paclitaxel in patients with advanced non-small cell lung cancerRoy S Herbst, Lisa A Hammond, David P Carbone, et al.
Cancer Research|June 19, 2007
Inhibition of epidermal growth factor receptor signaling elevates 15-hydroxyprostaglandin dehydrogenase in non-small-cell lung cancerLi Yang, Joseph M Amann, Takefumi Kikuchi, et al.
Cancer Research|November 13, 2003
Significance of p63 amplification and overexpression in lung cancer development and prognosisPierre P Massion, Peter M Taflan, S M Jamshedur Rahman, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 15, 2007
Cytoplasmic clusterin expression is associated with longer survival in patients with resected non small cell lung cancerJeffrey M Albert, Adriana Gonzalez, Pierre P Massion, et al.
Cancer Research|September 26, 2015
Multivalent Forms of the Notch Ligand DLL-1 Enhance Antitumor T-cell Immunity in Lung Cancer and Improve Efficacy of EGFR-Targeted TherapyAsel K Biktasova, Duafalia F Dudimah, Roman V Uzhachenko, et al.
Pageof 29

Showing results (161-170 of 283) with videos related to

Sort By:
Pageof 29
Cancer Gene Therapy|December 19, 2002
Recombinant adenoviruses expressing dominant negative insulin-like growth factor-I receptor demonstrate antitumor effects on lung cancerChoon-Taek Lee, Kyung-Ho Park, Yasushi Adachi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 27, 2009
Integration of molecular profiling into the lung cancer clinicWilliam Pao, Mark G Kris, A John Iafrate, et al.
Journal of Gastroenterology|November 11, 2009
Targeting for insulin-like growth factor-I receptor with short hairpin RNA for human digestive/gastrointestinal cancersYu Wang, Yasushi Adachi, Arisa Imsumran, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 14, 2019
Adaptive Resistance to Dual BRAF/MEK Inhibition in BRAF-Driven Tumors through Autocrine FGFR Pathway ActivationVictoria E Wang, Jenny Y Xue, Dennie T Frederick, et al.
JTO Clinical and Research Reports|June 20, 2022
Functional Trajectories and Resilience Among Adults With Advanced Lung CancerCarolyn J Presley, Nicole A Arrato, Peter G Shields, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 2, 2003
A phase I/IIA trial of continuous five-day infusion of squalamine lactate (MSI-1256F) plus carboplatin and paclitaxel in patients with advanced non-small cell lung cancerRoy S Herbst, Lisa A Hammond, David P Carbone, et al.
Cancer Research|June 19, 2007
Inhibition of epidermal growth factor receptor signaling elevates 15-hydroxyprostaglandin dehydrogenase in non-small-cell lung cancerLi Yang, Joseph M Amann, Takefumi Kikuchi, et al.
Cancer Research|November 13, 2003
Significance of p63 amplification and overexpression in lung cancer development and prognosisPierre P Massion, Peter M Taflan, S M Jamshedur Rahman, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 15, 2007
Cytoplasmic clusterin expression is associated with longer survival in patients with resected non small cell lung cancerJeffrey M Albert, Adriana Gonzalez, Pierre P Massion, et al.
Cancer Research|September 26, 2015
Multivalent Forms of the Notch Ligand DLL-1 Enhance Antitumor T-cell Immunity in Lung Cancer and Improve Efficacy of EGFR-Targeted TherapyAsel K Biktasova, Duafalia F Dudimah, Roman V Uzhachenko, et al.
Pageof 29